{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T04:58:55Z","timestamp":1783573135015,"version":"3.55.0"},"reference-count":145,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,3,15]],"date-time":"2025-03-15T00:00:00Z","timestamp":1741996800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,3,15]],"date-time":"2025-03-15T00:00:00Z","timestamp":1741996800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100024109","name":"Uniwersytet Gda\u0144ski","doi-asserted-by":"publisher","award":["531-D020-D242-23"],"award-info":[{"award-number":["531-D020-D242-23"]}],"id":[{"id":"10.13039\/501100024109","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Child Adolesc Psychiatry"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1007\/s00787-025-02661-5","type":"journal-article","created":{"date-parts":[[2025,3,15]],"date-time":"2025-03-15T03:09:29Z","timestamp":1742008169000},"page":"1795-1816","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Behavioural disorders and sleep problems in Sanfilippo syndrome: overlaps with some other conditions and importance indications"],"prefix":"10.1007","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3634-6567","authenticated-orcid":false,"given":"Karolina","family":"Wi\u015bniewska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jakub","family":"Wolski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7090-211X","authenticated-orcid":false,"given":"Paulina","family":"Anikiej-Wiczenbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4758-1394","authenticated-orcid":false,"given":"Magdalena","family":"\u017babi\u0144ska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grzegorz","family":"W\u0119grzyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4042-7466","authenticated-orcid":false,"given":"Karolina","family":"Pierzynowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,15]]},"reference":[{"issue":"7","key":"2661_CR1","doi-asserted-by":"publisher","first-page":"2515","DOI":"10.3390\/ijms21072515","volume":"21","author":"S Fecarotta","year":"2020","unstructured":"Fecarotta S, Tarallo A, Damiano C, Minopoli N, Parenti G (2020) Pathogenesis of mucopolysaccharidoses, an update. Int J Mol Sci 21(7):2515. https:\/\/doi.org\/10.3390\/ijms21072515","journal-title":"Int J Mol Sci"},{"issue":"3","key":"2661_CR2","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1007\/s13353-022-00703-1","volume":"63","author":"K Wi\u015bniewska","year":"2022","unstructured":"Wi\u015bniewska K, Wolski J, Gaffke L, Cyske Z, Pierzynowska K, W\u0119grzyn G (2022) Misdiagnosis in mucopolysaccharidoses. J Appl Genet 63(3):475\u2013495. https:\/\/doi.org\/10.1007\/s13353-022-00703-1","journal-title":"J Appl Genet"},{"issue":"1","key":"2661_CR3","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1186\/s13023-022-02484-6","volume":"17","author":"N Muschol","year":"2022","unstructured":"Muschol N, Giugliani R, Jones SA et al (2022) Sanfilippo syndrome: consensus guidelines for clinical care. Orphanet J Rare Dis 17(1):391. https:\/\/doi.org\/10.1186\/s13023-022-02484-6","journal-title":"Orphanet J Rare Dis"},{"issue":"3","key":"2661_CR4","doi-asserted-by":"publisher","first-page":"442","DOI":"10.3390\/genes13030442","volume":"13","author":"MC Faraguna","year":"2022","unstructured":"Faraguna MC, Musto F, Crescitelli V et al (2022) Mucopolysaccharidosis-plus syndrome, a rapidly progressive disease: favorable impact of a very prolonged steroid treatment on the clinical course in a child. Genes 13(3):442. https:\/\/doi.org\/10.3390\/genes13030442","journal-title":"Genes"},{"issue":"6","key":"2661_CR5","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.3390\/biomedicines11061668","volume":"11","author":"Z \u017buber","year":"2023","unstructured":"\u017buber Z, Kie\u0107-Wilk B, Ka\u0142u\u017cny \u0141, Wierzba J, Tylki-Szyma\u0144ska A (2023) Diagnosis and management of mucopolysaccharidosis type II (hunter syndrome) in Poland. Biomedicines 11(6):1668. https:\/\/doi.org\/10.3390\/biomedicines11061668","journal-title":"Biomedicines"},{"issue":"4","key":"2661_CR6","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.3390\/ijms21041258","volume":"21","author":"F D\u2019Avanzo","year":"2020","unstructured":"D\u2019Avanzo F, Rigon L, Zanetti A, Tomanin R (2020) Mucopolysaccharidosis type II: one hundred years of research, diagnosis, and treatment. Int J Mol Sci 21(4):1258. https:\/\/doi.org\/10.3390\/ijms21041258","journal-title":"Int J Mol Sci"},{"issue":"15","key":"2661_CR7","doi-asserted-by":"publisher","first-page":"7888","DOI":"10.3390\/ijms22157888","volume":"22","author":"CS Hampe","year":"2021","unstructured":"Hampe CS, Yund BD, Orchard PJ, Lund TC, Wesley J, McIvor RS (2021) Differences in MPS I and MPS II disease manifestations. Int J Mol Sci 22(15):7888. https:\/\/doi.org\/10.3390\/ijms22157888","journal-title":"Int J Mol Sci"},{"issue":"Suppl 2","key":"2661_CR8","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/s13052-018-0561-2","volume":"44","author":"R Barone","year":"2018","unstructured":"Barone R, Pellico A, Pittal\u00e0 A, Gasperini S (2018) Neurobehavioral phenotypes of neuronopathic mucopolysaccharidoses. Ital J Pediatr 44(Suppl 2):121. https:\/\/doi.org\/10.1186\/s13052-018-0561-2","journal-title":"Ital J Pediatr"},{"issue":"6","key":"2661_CR9","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.mehy.2010.07.044","volume":"75","author":"G W\u0119grzyn","year":"2010","unstructured":"W\u0119grzyn G, Jak\u00f3bkiewicz-Banecka J, Narajczyk M et al (2010) Why are behaviors of children suffering from various neuronopathic types of mucopolysaccharidoses different? Med Hypotheses 75(6):605\u2013609. https:\/\/doi.org\/10.1016\/j.mehy.2010.07.044","journal-title":"Med Hypotheses"},{"key":"2661_CR10","series-title":"Springer","first-page":"33","volume-title":"JIMD reports","author":"T Conijn","year":"2019","unstructured":"Conijn T, Nijmeijer SCM, van Oers HA, Wijburg FA, Haverman L (2019) Psychosocial functioning in parents of MPS III patients. In: Morava E, Baumgartner M, Patterson M, Rahman S, Zschocke J, Peters V (eds) JIMD reports, vol 44. Springer. Berlin, Heidelberg, pp 33\u201341"},{"issue":"1","key":"2661_CR11","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1186\/s13023-021-01767-8","volume":"16","author":"N Grant","year":"2021","unstructured":"Grant N (2021) Evaluating strategies to manage and endure challenging behaviors in mucopolysaccharidoses. Orphanet J Rare Dis 16(1):165. https:\/\/doi.org\/10.1186\/s13023-021-01767-8","journal-title":"Orphanet J Rare Dis"},{"key":"2661_CR12","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1186\/s13023-020-01548-9","volume":"15","author":"F Hoffmann","year":"2020","unstructured":"Hoffmann F, Hoffmann S, Kunzmann K, Ries M (2020) Challenging behavior in mucopolysaccharidoses types I-III and day-to-day coping strategies: a cross sectional explorative study. Orphanet J Rare Dis 15:275. https:\/\/doi.org\/10.1186\/s13023-020-01548-9","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"2661_CR13","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s40120-020-00226-z","volume":"10","author":"KA Porter","year":"2020","unstructured":"Porter KA, O\u2019Neill C, Drake E et al (2020) Parent experiences of sanfilippo syndrome impact and unmet treatment needs: a qualitative assessment. Neurol Ther 10(1):197\u2013212. https:\/\/doi.org\/10.1007\/s40120-020-00226-z","journal-title":"Neurol Ther"},{"issue":"1","key":"2661_CR14","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s41687-022-00447-w","volume":"6","author":"KA Porter","year":"2022","unstructured":"Porter KA, O\u2019Neill C, Drake E et al (2022) Caregivers\u2019 assessment of meaningful and relevant clinical outcome assessments for Sanfilippo syndrome. J Patient-Report Outcomes 6(1):40. https:\/\/doi.org\/10.1186\/s41687-022-00447-w","journal-title":"J Patient-Report Outcomes"},{"key":"2661_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ymgme.2017.08.009","volume":"122S","author":"EG Shapiro","year":"2017","unstructured":"Shapiro EG, Jones SA, Escolar ML (2017) Developmental and behavioral aspects of mucopolysaccharidoses with brain manifestations\u2014Neurological signs and symptoms. Mol Genet Metab 122S:1\u20137. https:\/\/doi.org\/10.1016\/j.ymgme.2017.08.009","journal-title":"Mol Genet Metab"},{"key":"2661_CR16","doi-asserted-by":"publisher","first-page":"263300402110207","DOI":"10.1177\/26330040211020764","volume":"2","author":"S Somanadhan","year":"2021","unstructured":"Somanadhan S, Bristow H, Crushell E et al (2021) IMPACT study: measuring the impact of caregiving on families and healthcare professionals of children and adults living with mucopolysaccharidoses in Ireland. Ther Adv Rare Dis 2:26330040211020764. https:\/\/doi.org\/10.1177\/26330040211020764","journal-title":"Ther Adv Rare Dis"},{"issue":"3","key":"2661_CR17","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1002\/jimd.12482","volume":"45","author":"S Hassall","year":"2022","unstructured":"Hassall S, Smith DM, Rust S, Wittkowski A (2022) A systematic review and integrative sequential explanatory narrative synthesis: the psychosocial impact of parenting a child with a lysosomal storage disorder. J Inherit Metab Dis 45(3):406\u2013416. https:\/\/doi.org\/10.1002\/jimd.12482","journal-title":"J Inherit Metab Dis"},{"issue":"1","key":"2661_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5582\/irdr.2020.01011","volume":"9","author":"J Zhou","year":"2020","unstructured":"Zhou J, Lin J, Leung WT, Wang L (2020) A basic understanding of mucopolysaccharidosis: incidence, clinical features, diagnosis, and management. Intractable Rare Dis Res 9(1):1\u20139. https:\/\/doi.org\/10.5582\/irdr.2020.01011","journal-title":"Intractable Rare Dis Res"},{"key":"2661_CR19","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s41687-022-00447-w","volume":"6","author":"KA Porter","year":"2022","unstructured":"Porter KA, O\u2019Neill C, Drake E et al (2022) Caregivers\u2019 assessment of meaningful and relevant clinical outcome assessments for Sanfilippo syndrome. J Patient Rep Outcomes 6:40. https:\/\/doi.org\/10.1186\/s41687-022-00447-w","journal-title":"J Patient Rep Outcomes"},{"issue":"5","key":"2661_CR20","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1111\/apa.12169","volume":"102","author":"FA Wijburg","year":"2013","unstructured":"Wijburg FA, W\u0119grzyn G, Burton BK, Tylki-Szyma\u0144ska A (2013) Mucopolysaccharidosis type III (Sanfilippo syndrome) and misdiagnosis of idiopathic developmental delay, attention deficit\/hyperactivity disorder or autism spectrum disorder. Acta Paediatr 102(5):462\u2013470. https:\/\/doi.org\/10.1111\/apa.12169","journal-title":"Acta Paediatr"},{"issue":"1","key":"2661_CR21","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s13023-018-0796-4","volume":"13","author":"T Zelei","year":"2018","unstructured":"Zelei T, Csetneki K, Vok\u00f3 Z, Siffel C (2018) Epidemiology of Sanfilippo syndrome: results of a systematic literature review. Orphanet J Rare Dis 13(1):53. https:\/\/doi.org\/10.1186\/s13023-018-0796-4","journal-title":"Orphanet J Rare Dis"},{"key":"2661_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2021.146090","volume":"812","author":"K Wi\u015bniewska","year":"2022","unstructured":"Wi\u015bniewska K, Gaffke L, Krzelowska K, W\u0119grzyn G, Pierzynowska K (2022) Differences in gene expression patterns, revealed by RNA-seq analysis, between various Sanfilippo and Morquio disease subtypes. Gene 812:146090. https:\/\/doi.org\/10.1016\/j.gene.2021.146090","journal-title":"Gene"},{"issue":"3","key":"2661_CR23","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.3390\/ijms21031156","volume":"21","author":"K Pierzynowska","year":"2020","unstructured":"Pierzynowska K, Gaffke L, Podlacha M, W\u0119grzyn G (2020) Genetic base of behavioral disorders in mucopolysaccharidoses: transcriptomic studies. Int J Mol Sci 21(3):1156. https:\/\/doi.org\/10.3390\/ijms21031156","journal-title":"Int J Mol Sci"},{"key":"2661_CR24","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s12920-022-01237-5","volume":"15","author":"M Saghi","year":"2022","unstructured":"Saghi M, InanlooRahatloo K, Alavi A, Kahrizi K, Najmabadi H (2022) Intellectual disability associated with craniofacial dysmorphism due to POLR3B mutation and defect in spliceosomal machinery. BMC Med Genom 15:89. https:\/\/doi.org\/10.1186\/s12920-022-01237-5","journal-title":"BMC Med Genom"},{"issue":"2","key":"2661_CR25","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/s10545-014-9737-0","volume":"38","author":"MMG Brands","year":"2015","unstructured":"Brands MMG, G\u00fcng\u00f6r D, van den Hout JMP et al (2015) Pain: a prevalent feature in patients with mucopolysaccharidosis. Results of a cross-sectional national survey. J Inherit Metab Dis 38(2):323\u2013331. https:\/\/doi.org\/10.1007\/s10545-014-9737-0","journal-title":"J Inherit Metab Dis"},{"issue":"1","key":"2661_CR26","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1186\/s13023-022-02402-w","volume":"17","author":"R Gnasso","year":"2022","unstructured":"Gnasso R, Corrado B, Iommazzo I et al (2022) Assessment, pharmacological therapy and rehabilitation management of musculoskeletal pain in children with mucopolysaccharidoses: a scoping review. Orphanet J Rare Dis 17(1):255. https:\/\/doi.org\/10.1186\/s13023-022-02402-w","journal-title":"Orphanet J Rare Dis"},{"issue":"19","key":"2661_CR27","doi-asserted-by":"publisher","first-page":"4445","DOI":"10.3390\/jcm10194445","volume":"10","author":"S Thomas","year":"2021","unstructured":"Thomas S, Ramaswami U, Cleary M, Yaqub M, Raebel EM (2021) Gastrointestinal manifestations in mucopolysaccharidosis type III: review of death certificates and the literature. J Clin Med 10(19):4445. https:\/\/doi.org\/10.3390\/jcm10194445","journal-title":"J Clin Med"},{"issue":"10","key":"2661_CR28","doi-asserted-by":"publisher","first-page":"3063","DOI":"10.3390\/ijms19103063","volume":"19","author":"S Congedi","year":"2018","unstructured":"Congedi S, Orzalesi M, Di Pede C, Benini F (2018) Pain in mucopolysaccharidoses: analysis of the problem and possible treatments. Int J Mol Sci 19(10):3063. https:\/\/doi.org\/10.3390\/ijms19103063","journal-title":"Int J Mol Sci"},{"issue":"2","key":"2661_CR29","doi-asserted-by":"publisher","DOI":"10.5395\/rde.2019.44.e14","volume":"44","author":"J-H Yoon","year":"2019","unstructured":"Yoon J-H, Lee H-I, Jang J-H et al (2019) Oral manifestation and root canal therapy of the patient with mucopolysaccharidosis. Restor Dent Endod 44(2):e14. https:\/\/doi.org\/10.5395\/rde.2019.44.e14","journal-title":"Restor Dent Endod"},{"key":"2661_CR30","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/7257230","volume":"2017","author":"S Congedi","year":"2017","unstructured":"Congedi S, Di Pede C, Scarpa M, Rampazzo A, Benini F (2017) The complexity of pain management in children affected by mucopolysaccharidoses. Case Rep Pediatr 2017:e7257230. https:\/\/doi.org\/10.1155\/2017\/7257230","journal-title":"Case Rep Pediatr"},{"issue":"3","key":"2661_CR31","doi-asserted-by":"publisher","first-page":"166","DOI":"10.3390\/jpm11030166","volume":"11","author":"L N\u00fa\u00f1ez-Jaramillo","year":"2021","unstructured":"N\u00fa\u00f1ez-Jaramillo L, Herrera-Sol\u00eds A, Herrera-Morales WV (2021) ADHD: reviewing the causes and evaluating solutions. J Person Med 11(3):166. https:\/\/doi.org\/10.3390\/jpm11030166","journal-title":"J Person Med"},{"issue":"7","key":"2661_CR32","doi-asserted-by":"publisher","first-page":"919","DOI":"10.3390\/brainsci12070919","volume":"12","author":"B Streeter","year":"2022","unstructured":"Streeter B, Sadek J (2022) Developmental risk, adversity experiences and ADHD clinical profiles: a naturalistic exploratory study. Brain Sci 12(7):919. https:\/\/doi.org\/10.3390\/brainsci12070919","journal-title":"Brain Sci"},{"issue":"1","key":"2661_CR33","doi-asserted-by":"publisher","first-page":"55","DOI":"10.21037\/tp.2019.09.09","volume":"9","author":"H Hodges","year":"2020","unstructured":"Hodges H, Fealko C, Soares N (2020) Autism spectrum disorder: definition, epidemiology, causes, and clinical evaluation. Transl Pediatr 9(1):55. https:\/\/doi.org\/10.21037\/tp.2019.09.09","journal-title":"Transl Pediatr"},{"issue":"1","key":"2661_CR34","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/bld.12248","volume":"47","author":"C Wolfenden","year":"2019","unstructured":"Wolfenden C, Wittkowski A, Jones SA, Rust S, Hare DJ (2019) Autism spectrum disorder symptomatology in children with mucopolysaccharide disease type III. Brit J Learn Disabil 47(1):5\u201311. https:\/\/doi.org\/10.1111\/bld.12248","journal-title":"Brit J Learn Disabil"},{"issue":"9","key":"2661_CR35","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1002\/mgg3.1356","volume":"8","author":"K Pierzynowska","year":"2020","unstructured":"Pierzynowska K, Ma\u0144ski A, Liman\u00f3wka M et al (2020) Untypically mild phenotype of a patient suffering from Sanfilippo syndrome B with the c.638C>T\/c.889C>T (p.Pro213Leu\/p.Arg297Ter) mutations in the NAGLU gene. Mol Genet Genom Med 8(9):1356. https:\/\/doi.org\/10.1002\/mgg3.1356","journal-title":"Mol Genet Genom Med"},{"issue":"2","key":"2661_CR36","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s10545-012-9572-0","volume":"36","author":"EM Cross","year":"2013","unstructured":"Cross EM, Hare DJ (2013) Behavioural phenotypes of the mucopolysaccharide disorders: a systematic literature review of cognitive, motor, social, linguistic and behavioural presentation in the MPS disorders. J Inherit Metab Dis 36(2):189\u2013200. https:\/\/doi.org\/10.1007\/s10545-012-9572-0","journal-title":"J Inherit Metab Dis"},{"issue":"2","key":"2661_CR37","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.ymgme.2014.12.001","volume":"114","author":"S Tomatsu","year":"2015","unstructured":"Tomatsu S, Alm\u00e9ciga-D\u00edaz CJ, Monta\u00f1o AM et al (2015) Therapies for the bone in mucopolysaccharidoses. Mol Genet Metab 114(2):94\u2013109. https:\/\/doi.org\/10.1016\/j.ymgme.2014.12.001","journal-title":"Mol Genet Metab"},{"issue":"10","key":"2661_CR38","doi-asserted-by":"publisher","first-page":"2937","DOI":"10.1007\/s00213-019-5180-0","volume":"236","author":"A Koz\u0142owska","year":"2019","unstructured":"Koz\u0142owska A, Wojtacha P, R\u00f3wniak M, Kolenkiewicz M, Huang ACW (2019) ADHD pathogenesis in the immune, endocrine and nervous systems of juvenile and maturating SHR and WKY rats. Psychopharmacology 236(10):2937\u20132958. https:\/\/doi.org\/10.1007\/s00213-019-5180-0","journal-title":"Psychopharmacology"},{"issue":"Suppl 2","key":"2661_CR39","doi-asserted-by":"publisher","first-page":"S402","DOI":"10.4103\/indianjpsychiatry.indianjpsychiatry_30_22","volume":"64","author":"KK Mishra","year":"2022","unstructured":"Mishra KK, Sawant N, Garg S (2022) Management of psychiatric disorders in patients with endocrine disorders. Indian J Psychiatry 64(Suppl 2):S402\u2013S413. https:\/\/doi.org\/10.4103\/indianjpsychiatry.indianjpsychiatry_30_22","journal-title":"Indian J Psychiatry"},{"issue":"4","key":"2661_CR40","doi-asserted-by":"publisher","first-page":"184","DOI":"10.6065\/apem.2014.19.4.184","volume":"19","author":"J Yu","year":"2014","unstructured":"Yu J (2014) Endocrine disorders and the neurologic manifestations. Ann Pediatr Endocrinol Metab 19(4):184\u2013190. https:\/\/doi.org\/10.6065\/apem.2014.19.4.184","journal-title":"Ann Pediatr Endocrinol Metab"},{"issue":"5","key":"2661_CR41","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1093\/brain\/awx327","volume":"141","author":"AG Murley","year":"2018","unstructured":"Murley AG, Rowe JB (2018) Neurotransmitter deficits from frontotemporal lobar degeneration. Brain 141(5):1263\u20131285. https:\/\/doi.org\/10.1093\/brain\/awx327","journal-title":"Brain"},{"issue":"4","key":"2661_CR42","doi-asserted-by":"publisher","first-page":"601","DOI":"10.3922\/j.psns.2014.4.20","volume":"7","author":"R Narvaes","year":"2014","unstructured":"Narvaes R, Martins De Almeida RM (2014) Aggressive behavior and three neurotransmitters: dopamine, GABA, and serotonin\u2014a review of the last 10 years. Psychol Neurosci 7(4):601\u2013607. https:\/\/doi.org\/10.3922\/j.psns.2014.4.20","journal-title":"Psychol Neurosci"},{"key":"2661_CR43","first-page":"151","volume-title":"Advances in genetics","author":"R Yanowitch","year":"2011","unstructured":"Yanowitch R, Coccaro EF (2011) Chapter 7\u2014the neurochemistry of human aggression. In: Huber R, Bannasch DL, Brennan P (eds) Advances in genetics. Academic Press, pp 151\u2013169"},{"key":"2661_CR44","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/B978-0-444-59602-4.00004-6","volume":"124","author":"R Bachner-Melman","year":"2014","unstructured":"Bachner-Melman R, Ebstein RP (2014) The role of oxytocin and vasopressin in emotional and social behaviors. Handb Clin Neurol 124:53\u201368. https:\/\/doi.org\/10.1016\/B978-0-444-59602-4.00004-6","journal-title":"Handb Clin Neurol"},{"issue":"21","key":"2661_CR45","doi-asserted-by":"publisher","first-page":"12077","DOI":"10.3390\/ijms222112077","volume":"22","author":"V Cid-Jofr\u00e9","year":"2021","unstructured":"Cid-Jofr\u00e9 V, Moreno M, Reyes-Parada M, Renard GM (2021) Role of oxytocin and vasopressin in neuropsychiatric disorders: therapeutic potential of agonists and antagonists. Int J Mol Sci 22(21):12077. https:\/\/doi.org\/10.3390\/ijms222112077","journal-title":"Int J Mol Sci"},{"key":"2661_CR46","doi-asserted-by":"publisher","first-page":"923","DOI":"10.3389\/fnins.2020.00923","volume":"14","author":"P Hepsomali","year":"2020","unstructured":"Hepsomali P, Groeger JA, Nishihira J, Scholey A (2020) Effects of oral gamma-aminobutyric acid (GABA) administration on stress and sleep in humans: a systematic review. Front Neurosci 14:923. https:\/\/doi.org\/10.3389\/fnins.2020.00923","journal-title":"Front Neurosci"},{"key":"2661_CR47","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.euroneuro.2017.12.007","volume":"30","author":"A Jager","year":"2020","unstructured":"Jager A, Amiri H, Bielczyk N et al (2020) Cortical control of aggression: GABA signalling in the anterior cingulate cortex. Eur Neuropsychopharmacol 30:5\u201316. https:\/\/doi.org\/10.1016\/j.euroneuro.2017.12.007","journal-title":"Eur Neuropsychopharmacol"},{"issue":"1","key":"2661_CR48","doi-asserted-by":"publisher","first-page":"91","DOI":"10.3390\/brainsci11010091","volume":"11","author":"PC Mamiya","year":"2021","unstructured":"Mamiya PC, Arnett AB, Stein MA (2021) Precision medicine care in ADHD: the case for neural excitation and inhibition. Brain Sci 11(1):91. https:\/\/doi.org\/10.3390\/brainsci11010091","journal-title":"Brain Sci"},{"key":"2661_CR49","doi-asserted-by":"publisher","DOI":"10.2174\/0929867322666150209152712","author":"P Purkayastha","year":"2015","unstructured":"Purkayastha P, Malapati A, Perumal Y, Sriram D (2015) A review on GABA\/glutamate pathway for therapeutic intervention of ASD and ADHD. Curr Med Chem. https:\/\/doi.org\/10.2174\/0929867322666150209152712","journal-title":"Curr Med Chem"},{"key":"2661_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.pscychresns.2020.111082","volume":"301","author":"NA Puts","year":"2020","unstructured":"Puts NA, Ryan M, Oeltzschner G, Horska A, Edden RAE, Mahone EM (2020) Reduced striatal GABA in unmedicated children with ADHD at 7T. Psychiatry Res Neuroimaging 301:111082. https:\/\/doi.org\/10.1016\/j.pscychresns.2020.111082","journal-title":"Psychiatry Res Neuroimaging"},{"key":"2661_CR51","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/j.nicl.2017.06.003","volume":"15","author":"MM Solleveld","year":"2017","unstructured":"Solleveld MM, Schrantee A, Puts NAJ, Reneman L, Lucassen PJ (2017) Age-dependent, lasting effects of methylphenidate on the GABAergic system of ADHD patients. Neuroimage 15:812\u2013818. https:\/\/doi.org\/10.1016\/j.nicl.2017.06.003","journal-title":"Neuroimage"},{"key":"2661_CR52","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.781327","volume":"9","author":"H Zhao","year":"2021","unstructured":"Zhao H, Mao X, Zhu C et al (2021) GABAergic system dysfunction in autism spectrum disorders. Front Cell Dev Biol 9:781327. https:\/\/doi.org\/10.3389\/fcell.2021.781327","journal-title":"Front Cell Dev Biol"},{"issue":"5","key":"2661_CR53","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1038\/s41380-020-00868-3","volume":"26","author":"M Andersson","year":"2021","unstructured":"Andersson M, Tangen \u00c4, Farde L et al (2021) Serotonin transporter availability in adults with autism\u2014a positron emission tomography study. Mol Psychiatry 26(5):1647\u20131658. https:\/\/doi.org\/10.1038\/s41380-020-00868-3","journal-title":"Mol Psychiatry"},{"key":"2661_CR54","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2022.919890","volume":"16","author":"F Zhao","year":"2022","unstructured":"Zhao F, Zhang H, Wang P et al (2022) Oxytocin and serotonin in the modulation of neural function: neurobiological underpinnings of autism-related behavior. Front Neurosci 16:919890. https:\/\/doi.org\/10.3389\/fnins.2022.919890","journal-title":"Front Neurosci"},{"issue":"1","key":"2661_CR55","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.brs.2019.08.016","volume":"13","author":"C Borwick","year":"2020","unstructured":"Borwick C, Lal R, Lim LW, Stagg CJ, Aquili L (2020) Dopamine depletion effects on cognitive flexibility as modulated by tDCS of the dlPFC. Brain Stimul 13(1):105\u2013108. https:\/\/doi.org\/10.1016\/j.brs.2019.08.016","journal-title":"Brain Stimul"},{"issue":"5","key":"2661_CR56","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.tins.2007.03.001","volume":"30","author":"P Calabresi","year":"2007","unstructured":"Calabresi P, Picconi B, Tozzi A, Di Filippo M (2007) Dopamine-mediated regulation of corticostriatal synaptic plasticity. Trends Neurosci 30(5):211\u2013219. https:\/\/doi.org\/10.1016\/j.tins.2007.03.001","journal-title":"Trends Neurosci"},{"key":"2661_CR57","first-page":"1","volume-title":"Endocrinology and systemic diseases","author":"J Salvador","year":"2020","unstructured":"Salvador J, Gutierrez G, Llavero M, Gargallo J, Escalada J, L\u00f3pez J (2020) Endocrine disorders and psychiatric manifestations. In: Portincasa P, Fr\u00fchbeck G, Nathoe HM (eds) Endocrinology and systemic diseases. Springer International Publishing, Cham, pp 1\u201335"},{"issue":"1","key":"2661_CR58","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41398-018-0134-6","volume":"8","author":"S Shin","year":"2018","unstructured":"Shin S, Kim S, Seo S et al (2018) The relationship between dopamine receptor blockade and cognitive performance in schizophrenia: a [11C]-raclopride PET study with aripiprazole. Transl Psychiatry 8(1):1\u20137. https:\/\/doi.org\/10.1038\/s41398-018-0134-6","journal-title":"Transl Psychiatry"},{"issue":"11","key":"2661_CR59","doi-asserted-by":"publisher","first-page":"365","DOI":"10.3390\/ph13110365","volume":"13","author":"SA Torrisi","year":"2020","unstructured":"Torrisi SA, Laudani S, Contarini G et al (2020) Dopamine, cognitive impairments and second-generation antipsychotics: from mechanistic advances to more personalized treatments. Pharmaceuticals 13(11):365. https:\/\/doi.org\/10.3390\/ph13110365","journal-title":"Pharmaceuticals"},{"issue":"1","key":"2661_CR60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41398-022-02003-y","volume":"12","author":"O Grimm","year":"2022","unstructured":"Grimm O, Thom\u00e4 L, Kranz TM, Reif A (2022) Is genetic risk of ADHD mediated via dopaminergic mechanism? A study of functional connectivity in ADHD and pharmacologically challenged healthy volunteers with a genetic risk profile. Transl Psychiatry 12(1):1\u20139. https:\/\/doi.org\/10.1038\/s41398-022-02003-y","journal-title":"Transl Psychiatry"},{"issue":"4","key":"2661_CR61","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s40474-019-00182-w","volume":"6","author":"TR Mehta","year":"2019","unstructured":"Mehta TR, Monegro A, Nene Y, Fayyaz M, Bollu PC (2019) Neurobiology of ADHD: a review. Curr Dev Disord Rep 6(4):235\u2013240. https:\/\/doi.org\/10.1007\/s40474-019-00182-w","journal-title":"Curr Dev Disord Rep"},{"issue":"3","key":"2661_CR62","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1007\/s12035-012-8278-5","volume":"45","author":"J Wu","year":"2012","unstructured":"Wu J, Xiao H, Sun H, Zou L, Zhu L-Q (2012) Role of dopamine receptors in ADHD: a systematic meta-analysis. Mol Neurobiol 45(3):605\u2013620. https:\/\/doi.org\/10.1007\/s12035-012-8278-5","journal-title":"Mol Neurobiol"},{"key":"2661_CR63","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2021.787097","volume":"12","author":"V Mandic-Maravic","year":"2022","unstructured":"Mandic-Maravic V, Grujicic R, Milutinovic L, Munjiza-Jovanovic A, Pejovic-Milovancevic M (2022) Dopamine in autism spectrum disorders\u2014focus on D2\/D3 partial agonists and their possible use in treatment. Front Psychiatry 12:787097. https:\/\/doi.org\/10.3389\/fpsyt.2021.787097","journal-title":"Front Psychiatry"},{"issue":"1","key":"2661_CR64","doi-asserted-by":"publisher","first-page":"3495","DOI":"10.1038\/s41467-021-23903-5","volume":"12","author":"M De Risi","year":"2021","unstructured":"De Risi M, Tufano M, Alvino FG et al (2021) Altered heparan sulfate metabolism during development triggers dopamine-dependent autistic-behaviours in models of lysosomal storage disorders. Nat Commun 12(1):3495. https:\/\/doi.org\/10.1038\/s41467-021-23903-5","journal-title":"Nat Commun"},{"issue":"9","key":"2661_CR65","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1210\/endocr\/bqac111","volume":"163","author":"N Rigney","year":"2022","unstructured":"Rigney N, de Vries GJ, Petrulis A, Young LJ (2022) Oxytocin, vasopressin, and social behavior: from neural circuits to clinical opportunities. Endocrinology 163(9):111. https:\/\/doi.org\/10.1210\/endocr\/bqac111","journal-title":"Endocrinology"},{"issue":"8","key":"2661_CR66","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1097\/FBP.0000000000000234","volume":"27","author":"E Demirci","year":"2016","unstructured":"Demirci E, Ozmen S, Kilic E, Oztop DB (2016) The relationship between aggression, empathy skills and serum oxytocin levels in male children and adolescents with attention deficit and hyperactivity disorder. Behav Pharmacol 27(8):681\u2013688. https:\/\/doi.org\/10.1097\/FBP.0000000000000234","journal-title":"Behav Pharmacol"},{"issue":"1","key":"2661_CR67","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41398-023-02524-0","volume":"13","author":"M Evenepoel","year":"2023","unstructured":"Evenepoel M, Moerkerke M, Daniels N et al (2023) Endogenous oxytocin levels in children with autism: associations with cortisol levels and oxytocin receptor gene methylation. Transl Psychiatry 13(1):1\u20139. https:\/\/doi.org\/10.1038\/s41398-023-02524-0","journal-title":"Transl Psychiatry"},{"issue":"5","key":"2661_CR68","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s12264-016-0046-5","volume":"32","author":"H-F Zhang","year":"2016","unstructured":"Zhang H-F, Dai Y-C, Wu J et al (2016) Plasma oxytocin and arginine-vasopressin levels in children with autism spectrum disorder in China: associations with symptoms. Neurosci Bull 32(5):423\u2013432. https:\/\/doi.org\/10.1007\/s12264-016-0046-5","journal-title":"Neurosci Bull"},{"issue":"19","key":"2661_CR69","doi-asserted-by":"publisher","first-page":"10609","DOI":"10.1073\/pnas.1919050117","volume":"117","author":"O Oztan","year":"2020","unstructured":"Oztan O, Garner JP, Constantino JN, Parker KJ (2020) Neonatal CSF vasopressin concentration predicts later medical record diagnoses of autism spectrum disorder. Proc Natl Acad Sci 117(19):10609\u201310613. https:\/\/doi.org\/10.1073\/pnas.1919050117","journal-title":"Proc Natl Acad Sci"},{"issue":"4","key":"2661_CR70","doi-asserted-by":"publisher","first-page":"3887","DOI":"10.3390\/ijms24043887","volume":"24","author":"K Pierzynowska","year":"2023","unstructured":"Pierzynowska K, Gaffke L, \u017babi\u0144ska M et al (2023) Roles of the oxytocin receptor (OXTR) in human diseases. Int J Mol Sci 24(4):3887. https:\/\/doi.org\/10.3390\/ijms24043887","journal-title":"Int J Mol Sci"},{"issue":"1","key":"2661_CR71","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s13052-019-0691-1","volume":"45","author":"A Cattoni","year":"2019","unstructured":"Cattoni A, Motta S, Masera N, Gasperini S, Rovelli A, Parini R (2019) The use of recombinant human growth hormone in patients with Mucopolysaccharidoses and growth hormone deficiency: a case series. Ital J Pediatr 45(1):93. https:\/\/doi.org\/10.1186\/s13052-019-0691-1","journal-title":"Ital J Pediatr"},{"issue":"3","key":"2661_CR72","doi-asserted-by":"publisher","first-page":"239","DOI":"10.5409\/wjcp.v11.i3.239","volume":"11","author":"MO Ogundele","year":"2022","unstructured":"Ogundele MO, Yemula C (2022) Management of sleep disorders among children and adolescents with neurodevelopmental disorders: a practical guide for clinicians. World J Clin Pediatr 11(3):239\u2013252. https:\/\/doi.org\/10.5409\/wjcp.v11.i3.239","journal-title":"World J Clin Pediatr"},{"issue":"1","key":"2661_CR73","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s11689-015-9126-5","volume":"7","author":"RA Mumford","year":"2015","unstructured":"Mumford RA, Mahon LV, Jones S, Bigger B, Canal M, Hare DJ (2015) Actigraphic investigation of circadian rhythm functioning and activity levels in children with mucopolysaccharidosis type III (Sanfilippo syndrome). J Neurodev Disord 7(1):31. https:\/\/doi.org\/10.1186\/s11689-015-9126-5","journal-title":"J Neurodev Disord"},{"issue":"12","key":"2661_CR74","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1136\/adc.2004.065482","volume":"90","author":"J Fraser","year":"2005","unstructured":"Fraser J, Gason A, Wraith J, Delatycki M (2005) Sleep disturbance in Sanfilippo syndrome: a parental questionnaire study. Arch Dis Child 90(12):1239\u20131242. https:\/\/doi.org\/10.1136\/adc.2004.065482","journal-title":"Arch Dis Child"},{"issue":"5","key":"2661_CR75","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1034\/j.1399-0004.2002.620512.x","volume":"62","author":"J Fraser","year":"2002","unstructured":"Fraser J, Wraith J, Delatycki M (2002) Sleep disturbance in mucopolysaccharidosis type III (Sanfilippo syndrome): a survey of managing clinicians. Clin Genet 62(5):418\u2013421. https:\/\/doi.org\/10.1034\/j.1399-0004.2002.620512.x","journal-title":"Clin Genet"},{"issue":"2","key":"2661_CR76","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0084128","volume":"9","author":"LV Mahon","year":"2014","unstructured":"Mahon LV, Lomax M, Grant S et al (2014) Assessment of sleep in children with mucopolysaccharidosis type III. PLoS ONE 9(2):e84128. https:\/\/doi.org\/10.1371\/journal.pone.0084128","journal-title":"PLoS ONE"},{"issue":"6","key":"2661_CR77","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1111\/j.1469-8749.1996.tb12114.x","volume":"38","author":"GA Colville","year":"1996","unstructured":"Colville GA, Walters JP, Yule W, Bax M (1996) Sleep problems in children with sanfilippo syndrome. Dev Med Child Neurol 38(6):538\u2013544. https:\/\/doi.org\/10.1111\/j.1469-8749.1996.tb12114.x","journal-title":"Dev Med Child Neurol"},{"key":"2661_CR78","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.ymgme.2017.09.010","volume":"122","author":"ML Escolar","year":"2017","unstructured":"Escolar ML, Jones SA, Shapiro EG, Horovitz DDG, Lampe C, Amartino H (2017) Practical management of behavioral problems in mucopolysaccharidoses disorders. Mol Genet Metab 122:35\u201340. https:\/\/doi.org\/10.1016\/j.ymgme.2017.09.010","journal-title":"Mol Genet Metab"},{"issue":"2","key":"2661_CR79","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s10545-012-9555-1","volume":"36","author":"KI Berger","year":"2013","unstructured":"Berger KI, Fagondes SC, Giugliani R et al (2013) Respiratory and sleep disorders in mucopolysaccharidosis. J Inherit Metab Dis 36(2):201\u2013210. https:\/\/doi.org\/10.1007\/s10545-012-9555-1","journal-title":"J Inherit Metab Dis"},{"key":"2661_CR80","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.ymgme.2017.08.008","volume":"122","author":"DM Rapoport","year":"2017","unstructured":"Rapoport DM, Mitchell JJ (2017) Pathophysiology, evaluation, and management of sleep disorders in the mucopolysaccharidoses. Mol Genet Metab 122:49\u201354. https:\/\/doi.org\/10.1016\/j.ymgme.2017.08.008","journal-title":"Mol Genet Metab"},{"key":"2661_CR81","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.ymgme.2017.10.006","volume":"122","author":"M Scarpa","year":"2017","unstructured":"Scarpa M, Louren\u00e7o CM, Amartino H (2017) Epilepsy in mucopolysaccharidosis disorders. Mol Genet Metab 122:55\u201361. https:\/\/doi.org\/10.1016\/j.ymgme.2017.10.006","journal-title":"Mol Genet Metab"},{"issue":"1","key":"2661_CR82","doi-asserted-by":"publisher","first-page":"e124","DOI":"10.1055\/s-0038-1667348","volume":"08","author":"DJ Hare","year":"2018","unstructured":"Hare DJ, Mahon L, Rust S (2018) Assessment and management of over-activity and sleep disorder in mucopolysaccharidoses. J Child Sci 08(1):e124\u2013e127. https:\/\/doi.org\/10.1055\/s-0038-1667348","journal-title":"J Child Sci"},{"issue":"2","key":"2661_CR83","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/s10545-014-9737-0","volume":"38","author":"MMG Brands","year":"2015","unstructured":"Brands MMG, G\u00fcng\u00f6r D, den van Hout JMP et al (2015) Pain: a prevalent feature in patients with mucopolysaccharidosis. Results of a cross-sectional national survey. J Inherit Metab Dis 38(2):323\u2013331. https:\/\/doi.org\/10.1007\/s10545-014-9737-0","journal-title":"J Inherit Metab Dis"},{"issue":"4","key":"2661_CR84","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1097\/j.pain.0000000000000095","volume":"156","author":"EL Sampson","year":"2015","unstructured":"Sampson EL, White N, Lord K et al (2015) Pain, agitation, and behavioural problems in people with dementia admitted to general hospital wards: a longitudinal cohort study. Pain 156(4):675\u2013683. https:\/\/doi.org\/10.1097\/j.pain.0000000000000095","journal-title":"Pain"},{"issue":"5","key":"2661_CR85","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1097\/01.ASM.0000751508.64877.83","volume":"85","author":"S Torbey","year":"2021","unstructured":"Torbey S, Rached G, Fiani D, Suleman M-I (2021) Psychiatric considerations in pediatric chronic pain. ASA Monitor 85(5):25\u201326. https:\/\/doi.org\/10.1097\/01.ASM.0000751508.64877.83","journal-title":"ASA Monitor"},{"issue":"1","key":"2661_CR86","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.jpainsymman.2018.03.023","volume":"56","author":"JM Politei","year":"2018","unstructured":"Politei JM, Gordillo-Gonz\u00e1lez G, Guelbert NB et al (2018) Recommendations for evaluation and management of pain in patients with mucopolysaccharidosis in Latin America. J Pain Symptom Manage 56(1):146\u2013152. https:\/\/doi.org\/10.1016\/j.jpainsymman.2018.03.023","journal-title":"J Pain Symptom Manage"},{"issue":"2","key":"2661_CR87","doi-asserted-by":"publisher","first-page":"99","DOI":"10.2217\/pmt.11.1","volume":"1","author":"JL Jackson","year":"2011","unstructured":"Jackson JL, Damm TW (2011) Barriers to the use of tricyclic antidepressants in the management of pain. Pain Manag 1(2):99\u2013101. https:\/\/doi.org\/10.2217\/pmt.11.1","journal-title":"Pain Manag"},{"issue":"1","key":"2661_CR88","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1093\/pch\/21.1.31","volume":"21","author":"Rieder MJ, Canadian Paediatric Society, Drug Therapy and Hazardous Substances Committee","year":"2016","unstructured":"Rieder MJ, Canadian Paediatric Society, Drug Therapy and Hazardous Substances Committee (2016) Is the medical use of cannabis a therapeutic option for children? Paediatr Child Health 21(1):31\u201334. https:\/\/doi.org\/10.1093\/pch\/21.1.31","journal-title":"Paediatr Child Health"},{"issue":"8","key":"2661_CR89","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1023\/a:1022935115323","volume":"25","author":"C Robinson","year":"2002","unstructured":"Robinson C, Baker N, Noble J et al (2002) The osteodystrophy of mucolipidosis type III and the effects of intravenous pamidronate treatment. J Inherit Metab Dis 25(8):681\u2013693. https:\/\/doi.org\/10.1023\/a:1022935115323","journal-title":"J Inherit Metab Dis"},{"issue":"3","key":"2661_CR90","doi-asserted-by":"publisher","first-page":"197","DOI":"10.2217\/pmt.14.13","volume":"4","author":"CG Vance","year":"2014","unstructured":"Vance CG, Dailey DL, Rakel BA, Sluka KA (2014) Using TENS for pain control: the state of the evidence. Pain Manag 4(3):197\u2013209. https:\/\/doi.org\/10.2217\/pmt.14.13","journal-title":"Pain Manag"},{"issue":"9","key":"2661_CR91","doi-asserted-by":"publisher","first-page":"3968","DOI":"10.1002\/14651858.CD003968.pub5","volume":"9","author":"E Fisher","year":"2018","unstructured":"Fisher E, Law E, Dudeney J, Palermo TM, Stewart G, Eccleston C (2018) Psychological therapies for the management of chronic and recurrent pain in children and adolescents. Cochrane Database Syst Rev 9(9):3968. https:\/\/doi.org\/10.1002\/14651858.CD003968.pub5","journal-title":"Cochrane Database Syst Rev"},{"issue":"24","key":"2661_CR92","doi-asserted-by":"publisher","first-page":"12882","DOI":"10.3390\/ijerph182412882","volume":"18","author":"MC del Rodr\u00edguez-Mart\u00ednez","year":"2021","unstructured":"del Rodr\u00edguez-Mart\u00ednez MC, de la Plana MA, Armenta-Peinado JA, Barbancho M\u00c1, Garc\u00eda-Casares N (2021) Evidence of animal-assisted therapy in neurological diseases in adults: a systematic review. Int J Environ Res Public Health 18(24):12882. https:\/\/doi.org\/10.3390\/ijerph182412882","journal-title":"Int J Environ Res Public Health"},{"issue":"1","key":"2661_CR93","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.ijnss.2020.12.009","volume":"8","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Yan F, Li S, Wang Y, Ma Y (2020) Effectiveness of animal-assisted therapy on pain in children: a systematic review and meta-analysis. Int J Nurs Sci 8(1):30\u201337. https:\/\/doi.org\/10.1016\/j.ijnss.2020.12.009","journal-title":"Int J Nurs Sci"},{"key":"2661_CR94","doi-asserted-by":"crossref","unstructured":"Laskowski B, Winkle MY, Molitor WL (2019) The meaning and motivation of children participating in animal-assisted therapy: a pilot study. 2:1","DOI":"10.62845\/20XLqBx"},{"issue":"2","key":"2661_CR95","first-page":"89","volume":"100","author":"RB Kelly","year":"2019","unstructured":"Kelly RB, Willis J (2019) Acupuncture for pain. Am Fam Physician 100(2):89\u201396","journal-title":"Am Fam Physician"},{"issue":"4","key":"2661_CR96","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.pneurobio.2008.05.004","volume":"85","author":"Z-Q Zhao","year":"2008","unstructured":"Zhao Z-Q (2008) Neural mechanism underlying acupuncture analgesia. Prog Neurobiol 85(4):355\u2013375. https:\/\/doi.org\/10.1016\/j.pneurobio.2008.05.004","journal-title":"Prog Neurobiol"},{"issue":"4","key":"2661_CR97","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/s0885-3924(02)00506-7","volume":"24","author":"LK Zeltzer","year":"2002","unstructured":"Zeltzer LK, Tsao JCI, Stelling C, Powers M, Levy S, Waterhouse M (2002) A phase I study on the feasibility and acceptability of an acupuncture\/hypnosis intervention for chronic pediatric pain. J Pain Symptom Manage 24(4):437\u2013446. https:\/\/doi.org\/10.1016\/s0885-3924(02)00506-7","journal-title":"J Pain Symptom Manage"},{"issue":"5","key":"2661_CR98","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1097\/01.ajp.0000194283.59132.fb","volume":"22","author":"RT Wilder","year":"2006","unstructured":"Wilder RT (2006) Management of pediatric patients with complex regional pain syndrome. Clin J Pain 22(5):443. https:\/\/doi.org\/10.1097\/01.ajp.0000194283.59132.fb","journal-title":"Clin J Pain"},{"issue":"1","key":"2661_CR99","doi-asserted-by":"publisher","first-page":"1","DOI":"10.17305\/bjbms.2017.2201","volume":"18","author":"BM Clark","year":"2018","unstructured":"Clark BM, Sprung J, Weingarten TN, Warner ME (2018) Anesthesia for patients with mucopolysaccharidoses: comprehensive review of the literature with emphasis on airway management. Bosn J Basic Med Sci 18(1):1\u20137. https:\/\/doi.org\/10.17305\/bjbms.2017.2201","journal-title":"Bosn J Basic Med Sci"},{"issue":"4","key":"2661_CR100","doi-asserted-by":"publisher","first-page":"538","DOI":"10.2174\/1570159X18666200529151741","volume":"19","author":"BJ Mano-Sousa","year":"2021","unstructured":"Mano-Sousa BJ, Pedrosa AM, Alves BC et al (2021) Effects of risperidone in autistic children and young adults: a systematic review and meta-analysis. Curr Neuropharmacol 19(4):538. https:\/\/doi.org\/10.2174\/1570159X18666200529151741","journal-title":"Curr Neuropharmacol"},{"key":"2661_CR101","doi-asserted-by":"publisher","DOI":"10.1590\/1984-0462\/2021\/39\/2019397","volume":"39","author":"ATD Irigonh\u00ea","year":"2020","unstructured":"Irigonh\u00ea ATD, Moreira AMT, Valle DA, do Santos MLSF (2020) Mucopolysacaridosis type IIIB misdiagnosed as an autistic spectrum disorder: a case report and literature review. Rev paul pediatr 39:e2019397. https:\/\/doi.org\/10.1590\/1984-0462\/2021\/39\/2019397","journal-title":"Rev paul pediatr"},{"issue":"1","key":"2661_CR102","doi-asserted-by":"publisher","first-page":"15","DOI":"10.14740\/ijcp237w","volume":"5","author":"C Ugur","year":"2016","unstructured":"Ugur C, Tunas SD, Uneri OS, Goker Z, Cetinkaya M (2016) Atomoxetine treatment for attention deficit and hyperactivity disorder symptoms in a child who has mucopolysaccharidosis type IIIB disorder. Int J Clin Pediatr 5(1):15\u201318","journal-title":"Int J Clin Pediatr"},{"issue":"bcr07","key":"2661_CR103","doi-asserted-by":"publisher","first-page":"0480","DOI":"10.1136\/bcr.07.2008.0480","volume":"2009","author":"P Santosh","year":"2008","unstructured":"Santosh P, Parker JR (2008) Psychopharmacological treatment of behavioural problems in Sanfilippo syndrome. BMJ Case Rep 2009(bcr07):0480. https:\/\/doi.org\/10.1136\/bcr.07.2008.0480","journal-title":"BMJ Case Rep"},{"issue":"2","key":"2661_CR104","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.braindev.2008.12.010","volume":"32","author":"S Kalkan Ucar","year":"2010","unstructured":"Kalkan Ucar S, Ozbaran B, Demiral N, Yuncu Z, Erermis S, Coker M (2010) Clinical overview of children with mucopolysaccharidosis type III A and effect of Risperidone treatment on children and their mothers psychological status. Brain Dev 32(2):156\u2013161. https:\/\/doi.org\/10.1016\/j.braindev.2008.12.010","journal-title":"Brain Dev"},{"issue":"1\u20132","key":"2661_CR105","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.ymgme.2016.09.005","volume":"120","author":"F Kubaski","year":"2017","unstructured":"Kubaski F, Osago H, Mason RW et al (2017) Glycosaminoglycans detection methods: applications of mass spectrometry. Mol Genet Metab 120(1\u20132):67\u201377. https:\/\/doi.org\/10.1016\/j.ymgme.2016.09.005","journal-title":"Mol Genet Metab"},{"issue":"2","key":"2661_CR106","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1007\/s40489-021-00298-z","volume":"10","author":"KA Schreck","year":"2023","unstructured":"Schreck KA, Knapp LM (2023) MPS-IIIA or autism spectrum disorder?: Discrimination and treatment. Rev J Autism Dev Disord 10(2):383\u2013390. https:\/\/doi.org\/10.1007\/s40489-021-00298-z","journal-title":"Rev J Autism Dev Disord"},{"issue":"4","key":"2661_CR107","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1007\/s10882-018-9601-5","volume":"30","author":"KA Schreck","year":"2018","unstructured":"Schreck KA, Helsel C, Paxon A, Weston K, Daniels M (2018) Regression trends & treatment effectiveness to improve quality of life for a pre-adolescent girl with MPS IIIA. J Dev Phys Disabil 30(4):545\u2013558. https:\/\/doi.org\/10.1007\/s10882-018-9601-5","journal-title":"J Dev Phys Disabil"},{"issue":"3","key":"2661_CR108","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1007\/s40614-022-00338-x","volume":"45","author":"M Gitimoghaddam","year":"2022","unstructured":"Gitimoghaddam M, Chichkine N, McArthur L, Sangha SS, Symington V (2022) Applied behavior analysis in children and youth with autism spectrum disorders: a scoping review. Perspect Behav Sci 45(3):521\u2013557. https:\/\/doi.org\/10.1007\/s40614-022-00338-x","journal-title":"Perspect Behav Sci"},{"key":"2661_CR109","first-page":"01","volume":"3","author":"J Leonardi","year":"2012","unstructured":"Leonardi J, Rubano D (2012) Empirical foundations of applied behavior analysis for the treatment of attention deficit-hyperactivity disorder (ADHD). Pepsic 3:01\u201319","journal-title":"Pepsic"},{"issue":"4","key":"2661_CR110","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/j.chc.2014.05.014","volume":"23","author":"LJ Pfiffner","year":"2014","unstructured":"Pfiffner LJ, Haack LM (2014) Behavior management for school aged children with ADHD. Child Adolesc Psychiatr Clin N Am 23(4):731. https:\/\/doi.org\/10.1016\/j.chc.2014.05.014","journal-title":"Child Adolesc Psychiatr Clin N Am"},{"issue":"1","key":"2661_CR111","doi-asserted-by":"publisher","first-page":"114","DOI":"10.21037\/tp.2019.10.01","volume":"9","author":"M Shrestha","year":"2020","unstructured":"Shrestha M, Lautenschleger J, Soares N (2020) Non-pharmacologic management of attention-deficit\/hyperactivity disorder in children and adolescents: a review. Transl Pediatr 9(1):114\u2013124. https:\/\/doi.org\/10.21037\/tp.2019.10.01","journal-title":"Transl Pediatr"},{"issue":"3","key":"2661_CR112","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1002\/rev3.3149","volume":"6","author":"DA Moore","year":"2018","unstructured":"Moore DA, Russell AE, Matthews J et al (2018) School-based interventions for attention-deficit\/hyperactivity disorder: a systematic review with multiple synthesis methods. Rev Educ 6(3):209\u2013263. https:\/\/doi.org\/10.1002\/rev3.3149","journal-title":"Rev Educ"},{"issue":"5","key":"2661_CR113","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1001\/archpediatrics.2010.40","volume":"164","author":"K Sayal","year":"2010","unstructured":"Sayal K, Owen V, White K, Merrell C, Tymms P, Taylor E (2010) Impact of early school-based screening and intervention programs for ADHD on children\u2019s outcomes and access to services: follow-up of a school-based trial at age 10 years. Arch Pediatr Adolesc Med 164(5):462\u2013469. https:\/\/doi.org\/10.1001\/archpediatrics.2010.40","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"5","key":"2661_CR114","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1007\/s10578-022-01345-4","volume":"54","author":"T Nguyen","year":"2023","unstructured":"Nguyen T, Elkins SR, Curtis DF (2023) Peer-based intervention for socioemotional concerns among children with ADHD. Child Psychiatry Hum Dev 54(5):1386\u20131395. https:\/\/doi.org\/10.1007\/s10578-022-01345-4","journal-title":"Child Psychiatry Hum Dev"},{"issue":"7","key":"2661_CR115","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0180355","volume":"12","author":"F Catal\u00e1-L\u00f3pez","year":"2017","unstructured":"Catal\u00e1-L\u00f3pez F, Hutton B, N\u00fa\u00f1ez-Beltr\u00e1n A et al (2017) The pharmacological and non-pharmacological treatment of attention deficit hyperactivity disorder in children and adolescents: a systematic review with network meta-analyses of randomised trials. PLoS ONE 12(7):e0180355. https:\/\/doi.org\/10.1371\/journal.pone.0180355","journal-title":"PLoS ONE"},{"issue":"3","key":"2661_CR116","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0193681","volume":"13","author":"KCM Bul","year":"2018","unstructured":"Bul KCM, Doove LL, Franken IHA, der Oord SV, Kato PM, Maras A (2018) A serious game for children with attention deficit hyperactivity disorder: who benefits the most? PLoS ONE 13(3):e0193681. https:\/\/doi.org\/10.1371\/journal.pone.0193681","journal-title":"PLoS ONE"},{"key":"2661_CR117","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2022.114509","volume":"311","author":"W Sun","year":"2022","unstructured":"Sun W, Yu M, Zhou X (2022) Effects of physical exercise on attention deficit and other major symptoms in children with ADHD: a meta-analysis. Psychiatry Res 311:114509. https:\/\/doi.org\/10.1016\/j.psychres.2022.114509","journal-title":"Psychiatry Res"},{"issue":"1","key":"2661_CR118","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s13034-022-00539-x","volume":"17","author":"CG Lim","year":"2023","unstructured":"Lim CG, Soh CP, Lim SSY, Fung DSS, Guan C, Lee T-S (2023) Home-based brain\u2013computer interface attention training program for attention deficit hyperactivity disorder: a feasibility trial. Child Adolesc Psychiatry Ment Health 17(1):15. https:\/\/doi.org\/10.1186\/s13034-022-00539-x","journal-title":"Child Adolesc Psychiatry Ment Health"},{"key":"2661_CR119","first-page":"40","volume":"12","author":"A Ko\u0142akowski","year":"2012","unstructured":"Ko\u0142akowski A (2012) Neurofeedback and multimodal treatment of ADHD. Psychiatria i Psychologia Kliniczna 12:40\u201351","journal-title":"Psychiatria i Psychologia Kliniczna"},{"issue":"6","key":"2661_CR120","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1007\/s11920-019-1021-4","volume":"21","author":"S Enriquez-Geppert","year":"2019","unstructured":"Enriquez-Geppert S, Smit D, Pimenta MG, Arns M (2019) Neurofeedback as a treatment intervention in ADHD: current evidence and practice. Curr Psychiatry Rep 21(6):46. https:\/\/doi.org\/10.1007\/s11920-019-1021-4","journal-title":"Curr Psychiatry Rep"},{"key":"2661_CR121","doi-asserted-by":"publisher","first-page":"2297","DOI":"10.1007\/978-1-4614-4788-7_57","volume-title":"Comprehensive guide to autism","author":"S Rodger","year":"2014","unstructured":"Rodger S, Polatajko HJ (2014) Occupational therapy for children with autism. In: Patel VB, Preedy VR, Martin CR (eds) Comprehensive guide to autism. Springer, New York, pp 2297\u20132314"},{"issue":"2","key":"2661_CR122","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1177\/15394492221103850","volume":"43","author":"J Sterman","year":"2023","unstructured":"Sterman J, Gustafson E, Eisenmenger L, Hamm L, Edwards J (2023) Autistic adult perspectives on occupational therapy for autistic children and youth. Occup Therapy J Res 43(2):237\u2013244. https:\/\/doi.org\/10.1177\/15394492221103850","journal-title":"Occup Therapy J Res"},{"key":"2661_CR123","first-page":"1","volume-title":"Encyclopedia of autism spectrum disorders","author":"C Kasari","year":"2018","unstructured":"Kasari C, Shire SY (2018) JASPER. In: Volkmar FR (ed) Encyclopedia of autism spectrum disorders. Springer, New York, pp 1\u20137"},{"issue":"1","key":"2661_CR124","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5409\/wjcp.v12.i1.1","volume":"12","author":"R Elbeltagi","year":"2023","unstructured":"Elbeltagi R, Al-Beltagi M, Saeed NK, Alhawamdeh R (2023) Play therapy in children with autism: its role, implications, and limitations. World J Clin Pediatr 12(1):1\u201322. https:\/\/doi.org\/10.5409\/wjcp.v12.i1.1","journal-title":"World J Clin Pediatr"},{"issue":"4","key":"2661_CR125","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.jen.2018.12.002","volume":"45","author":"EB Wood","year":"2019","unstructured":"Wood EB, Halverson A, Harrison G, Rosenkranz A (2019) Creating a sensory-friendly pediatric emergency department. J Emerg Nurs 45(4):415\u2013424. https:\/\/doi.org\/10.1016\/j.jen.2018.12.002","journal-title":"J Emerg Nurs"},{"issue":"9","key":"2661_CR126","doi-asserted-by":"publisher","first-page":"2876","DOI":"10.1007\/s10803-015-2450-5","volume":"45","author":"SA Cermak","year":"2015","unstructured":"Cermak SA, Stein Duker LI, Williams ME, Dawson ME, Lane CJ, Polido JC (2015) Sensory adapted dental environments to enhance oral care for children with autism spectrum disorders: a randomized controlled pilot study. J Autism Dev Disord 45(9):2876\u20132888. https:\/\/doi.org\/10.1007\/s10803-015-2450-5","journal-title":"J Autism Dev Disord"},{"issue":"9","key":"2661_CR127","doi-asserted-by":"publisher","first-page":"3369","DOI":"10.1007\/s10803-022-05651-7","volume":"53","author":"S Litwin","year":"2023","unstructured":"Litwin S, Sellen K (2023) Designing a sensory kit to improve the environment for children with autism spectrum disorder in the pediatric emergency department. J Autism Dev Disord 53(9):3369\u20133379. https:\/\/doi.org\/10.1007\/s10803-022-05651-7","journal-title":"J Autism Dev Disord"},{"issue":"1","key":"2661_CR128","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1007\/s44202-024-00118-5","volume":"4","author":"L Rios-Vega","year":"2024","unstructured":"Rios-Vega L, Carroll A, Dumont R, Treadwell-Deering D, Fields M, Schaaf R (2024) Designing sensory adaptive environments to enhance participation in healthcare for autistic children. Discov Psychol 4(1):22. https:\/\/doi.org\/10.1007\/s44202-024-00118-5","journal-title":"Discov Psychol"},{"issue":"2","key":"2661_CR129","doi-asserted-by":"publisher","first-page":"709","DOI":"10.3892\/ijmm.2017.3287","volume":"41","author":"J He","year":"2018","unstructured":"He J, Zhao C, Liu W et al (2018) Neurochemical changes in the hippocampus and prefrontal cortex associated with electroacupuncture for learning and memory impairment. Int J Mol Med 41(2):709\u2013716. https:\/\/doi.org\/10.3892\/ijmm.2017.3287","journal-title":"Int J Mol Med"},{"key":"2661_CR130","doi-asserted-by":"publisher","first-page":"802","DOI":"10.3389\/fpsyt.2020.00802","volume":"11","author":"J Shen","year":"2020","unstructured":"Shen J, Shenkar D, An L, Tomar JS (2020) Local and interregional neurochemical associations measured by magnetic resonance spectroscopy for studying brain functions and psychiatric disorders. Front Psychiatry 11:802. https:\/\/doi.org\/10.3389\/fpsyt.2020.00802","journal-title":"Front Psychiatry"},{"key":"2661_CR131","doi-asserted-by":"publisher","first-page":"2335","DOI":"10.1038\/s41467-020-16090-2","volume":"11","author":"J Michely","year":"2020","unstructured":"Michely J, Eldar E, Martin IM, Dolan RJ (2020) A mechanistic account of serotonin\u2019s impact on mood. Nat Commun 11:2335. https:\/\/doi.org\/10.1038\/s41467-020-16090-2","journal-title":"Nat Commun"},{"issue":"1","key":"2661_CR132","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1007\/s13311-022-01183-1","volume":"19","author":"R Aishworiya","year":"2022","unstructured":"Aishworiya R, Valica T, Hagerman R, Restrepo B (2022) An update on psychopharmacological treatment of autism spectrum disorder. Neurotherapeutics 19(1):248\u2013262. https:\/\/doi.org\/10.1007\/s13311-022-01183-1","journal-title":"Neurotherapeutics"},{"key":"2661_CR133","doi-asserted-by":"publisher","first-page":"1066988","DOI":"10.3389\/fphar.2022.1066988","volume":"13","author":"VA Nazarova","year":"2022","unstructured":"Nazarova VA, Sokolov AV, Chubarev VN, Tarasov VV, Schi\u00f6th HB (2022) Treatment of ADHD: drugs, psychological therapies, devices, complementary and alternative methods as well as the trends in clinical trials. Front Pharmacol 13:1066988. https:\/\/doi.org\/10.3389\/fphar.2022.1066988","journal-title":"Front Pharmacol"},{"issue":"4","key":"2661_CR134","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1016\/j.ymthe.2022.01.037","volume":"30","author":"A Capuozzo","year":"2022","unstructured":"Capuozzo A, Montefusco S, Cacace V et al (2022) Fluoxetine ameliorates mucopolysaccharidosis type IIIA. Mol Ther 30(4):1432\u20131450. https:\/\/doi.org\/10.1016\/j.ymthe.2022.01.037","journal-title":"Mol Ther"},{"issue":"2","key":"2661_CR135","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1038\/s41380-022-01845-8","volume":"28","author":"AJ Guastella","year":"2023","unstructured":"Guastella AJ, Boulton KA, Whitehouse AJO et al (2023) The effect of oxytocin nasal spray on social interaction in young children with autism: a randomized clinical trial. Mol Psychiatry 28(2):834\u2013842. https:\/\/doi.org\/10.1038\/s41380-022-01845-8","journal-title":"Mol Psychiatry"},{"issue":"10","key":"2661_CR136","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1007\/s00228-023-03545-w","volume":"79","author":"L Hu","year":"2023","unstructured":"Hu L, Du X, Jiang Z, Song C, Liu D (2023) Oxytocin treatment for core symptoms in children with autism spectrum disorder: a systematic review and meta-analysis. Eur J Clin Pharmacol 79(10):1357\u20131363. https:\/\/doi.org\/10.1007\/s00228-023-03545-w","journal-title":"Eur J Clin Pharmacol"},{"issue":"10","key":"2661_CR137","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.3390\/biomedicines11102603","volume":"11","author":"K L\u00e1szl\u00f3","year":"2023","unstructured":"L\u00e1szl\u00f3 K, V\u00f6r\u00f6s D, Correia P et al (2023) Vasopressin as possible treatment option in autism spectrum disorder. Biomedicines 11(10):2603. https:\/\/doi.org\/10.3390\/biomedicines11102603","journal-title":"Biomedicines"},{"issue":"3","key":"2661_CR138","doi-asserted-by":"publisher","first-page":"416","DOI":"10.3390\/ph16030416","volume":"16","author":"A-M Wiesinger","year":"2023","unstructured":"Wiesinger A-M, Strobl H, Lagler FB (2023) Individual treatment trials\u2014do experts know and use this option to improve the treatability of mucopolysaccharidosis? Pharmaceuticals 16(3):416. https:\/\/doi.org\/10.3390\/ph16030416","journal-title":"Pharmaceuticals"},{"issue":"21","key":"2661_CR139","doi-asserted-by":"publisher","first-page":"5428","DOI":"10.3390\/cancers13215428","volume":"13","author":"M Kyr","year":"2021","unstructured":"Kyr M, Svobodnik A, Stepanova R, Hejnova R (2021) N-of-1 trials in pediatric oncology: from a population-based approach to personalized medicine-a review. Cancers (Basel) 13(21):5428. https:\/\/doi.org\/10.3390\/cancers13215428","journal-title":"Cancers (Basel)"},{"issue":"1","key":"2661_CR140","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1007\/s11606-019-05303-0","volume":"35","author":"DD Odineal","year":"2020","unstructured":"Odineal DD, Marois MT, Ward D et al (2020) Effect of mobile device-assisted N-of-1 trial participation on analgesic prescribing for chronic pain: randomized controlled trial. J Gen Intern Med 35(1):102\u2013111. https:\/\/doi.org\/10.1007\/s11606-019-05303-0","journal-title":"J Gen Intern Med"},{"issue":"4","key":"2661_CR141","doi-asserted-by":"publisher","first-page":"238","DOI":"10.5582\/irdr.2021.01104","volume":"10","author":"A Fung","year":"2021","unstructured":"Fung A, Yue X, Wigle PR, Guo JJ (2021) Off-label medication use in rare pediatric diseases in the United States. Intractable Rare Dis Res 10(4):238\u2013245. https:\/\/doi.org\/10.5582\/irdr.2021.01104","journal-title":"Intractable Rare Dis Res"},{"key":"2661_CR142","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.jclinepi.2017.09.015","volume":"93","author":"AJ Clough","year":"2018","unstructured":"Clough AJ, Hilmer SN, Naismith SL, Kardell LD, Gnjidic D (2018) N-of-1 trials for assessing the effects of deprescribing medications on short-term clinical outcomes in older adults: a systematic review. J Clin Epidemiol 93:112\u2013119. https:\/\/doi.org\/10.1016\/j.jclinepi.2017.09.015","journal-title":"J Clin Epidemiol"},{"key":"2661_CR143","doi-asserted-by":"publisher","first-page":"110","DOI":"10.3389\/fnut.2019.00110","volume":"6","author":"N Soldevila-Domenech","year":"2019","unstructured":"Soldevila-Domenech N, Boronat A, Langohr K, de la Torre R (2019) N-of-1 clinical trials in nutritional interventions directed at improving cognitive function. Front Nutr 6:110. https:\/\/doi.org\/10.3389\/fnut.2019.00110","journal-title":"Front Nutr"},{"issue":"9","key":"2661_CR144","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1002\/ajmg.a.38326","volume":"173","author":"W Sun","year":"2017","unstructured":"Sun W, Zheng W, Simeonov A (2017) Drug discovery and development for rare genetic disorders. Am J Med Genet A 173(9):2307\u20132322. https:\/\/doi.org\/10.1002\/ajmg.a.38326","journal-title":"Am J Med Genet A"},{"issue":"6","key":"2661_CR145","doi-asserted-by":"publisher","first-page":"A10","DOI":"10.1136\/archdischild-2023-ESDPPP.30","volume":"108","author":"A-M Wiesinger","year":"2023","unstructured":"Wiesinger A-M, Lagler F, Scarpa M, Giugliani R, Lampe C, Kampmann C (2023) 30 Utilization of and barriers to individual treatment trials in mucopolysaccharidosis\u2014interim results of an expert survey. Arch Dis Child 108(6):A10\u2013A10. https:\/\/doi.org\/10.1136\/archdischild-2023-ESDPPP.30","journal-title":"Arch Dis Child"}],"container-title":["European Child & Adolescent Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00787-025-02661-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00787-025-02661-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00787-025-02661-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T05:07:40Z","timestamp":1750828060000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00787-025-02661-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,15]]},"references-count":145,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["2661"],"URL":"https:\/\/doi.org\/10.1007\/s00787-025-02661-5","relation":{},"ISSN":["1018-8827","1435-165X"],"issn-type":[{"value":"1018-8827","type":"print"},{"value":"1435-165X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,15]]},"assertion":[{"value":"25 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}